BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 16, 2003
View Archived Issues
Celltech Poised To Acquire OGS After Other Parties Drop Interest
LONDON - Oxford GlycoSciences plc succumbed to the hostile bid from Celltech plc that will lead to the breakup of the business, after failing to attract any better offers. (BioWorld International)
Read More
Oxxon Completes £15M Round To Fund Therapeutic Vaccines
Read More
Engineered Lymphocytes Show Promise In Metastatic Cancer
Read More
Karo Bio Plans To Net SEK120M From Discounted Rights Issue
Read More
Affitech, NatImmune Team Up In Colon Cancer Collaboration
Read More
Entomed, Achillion Enter Deal For Antiviral Drug Discovery
Read More
European Parliament Moves For Strict Cell, Tissue Rules
Read More
EU Consumer Commissioner Favors Progress In Biotech
Read More
IDM Acquires Cancer Assets For Stock In Deal With Jenner
Read More
Proteome Sciences, IDEXX Enter Deal To Develop BSE Diagnostic
Read More
MedPharma Looking To Go Public To Fund Sexual Dysfunction Drugs
Read More
Other News To Note
Read More